Effectiveness of a Home-based Pulmonary Rehabilitation Program in COPD Patients
Launched by UNIDADE LOCAL DE SAÚDE DE MATOSINHOS, EPE · Mar 29, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new home-based program designed to help people with Chronic Obstructive Pulmonary Disease (COPD) improve their breathing and overall health. The program has two parts: the first part lasts for 8 weeks and focuses on respiratory rehabilitation, while the second part helps participants maintain their progress after the initial program. Researchers want to see if this approach can effectively support COPD patients in their own homes.
To be eligible for the trial, participants need to have a confirmed diagnosis of COPD and live in the area where the study is taking place. However, individuals who have recently gone through a pulmonary rehabilitation program, experienced a COPD flare-up, or have certain serious health conditions may not qualify. Participants can expect to engage in exercises and activities designed to improve their lung function and quality of life from the comfort of their home. This trial is currently looking for volunteers, and it’s an excellent opportunity for those with COPD to receive support tailored to their needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • COPD diagnose with B or E characterization according to GOLD criteria;
- • Residence in the area covered by the institution where the study is carried out
- Exclusion Criteria:
- • Frequency of a PR programme in the previous six months
- • COPD exacerbation for less than one week;
- • Presence of unstable comorbidities (List of predetermined diagnoses that constitute absolute exclusion criteria);
- • Presence of comorbidities that constitute relative exclusion criteria through a medical evaluation.
- • Score of the Clinical Frailty Scale 2.0 above six or above five in case of not having a responsible caregiver and living alone
- • SpO2 below 85% in the 6-minute walk test
About Unidade Local De Saúde De Matosinhos, Epe
Unidade Local de Saúde de Matosinhos, EPE, is a prominent healthcare institution in Portugal, dedicated to providing comprehensive health services and advancing medical research. As a clinical trial sponsor, it is committed to enhancing patient care through innovative studies and evidence-based practices. The organization fosters collaboration among healthcare professionals, researchers, and patients to facilitate the development of new therapies and improve health outcomes. With a focus on ethical standards and rigorous scientific methodology, Unidade Local de Saúde de Matosinhos aims to contribute significantly to the advancement of medical knowledge and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Matosinhos, Porto, Portugal
Patients applied
Trial Officials
Liliana Silva, MSc
Principal Investigator
Matosinhos Local Health Unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials